Eden Research Plc
Eden Research is an encapsulation development company that utilises natural, plant-derived essential oils “Terpenes” to manufacture low-risk environmentally-friendly products. The company has a patented Encapsulation Delivery System (EDS) to release these natural compounds for agricultural and non- agricultural uses. In agriculture, the products have applications as fungicides, bactericides and nematicides to combat plant diseases as well as natural pests which reduce crop yields. Outside of agrochemicals, Eden’s technologies have applications in human and animal health, cosmetics as well as the biocide market. Agreements have been signed with Bayer Animal Health, FMC Corporation in the US and Xeda International in France.
Exchange:London AIM (EDEN)
Financial Data from Exchange Website : LSE Summary
nt Marketing Report: Extension of patent protection in Greece
There has been little financial information from Eden Research for some time. In mid May 2016 there was news of a successful placing which has raised £2.6million before expenses with new and existing institutional shareholders. The raise was run by Shore Capital Stockbrokers through the issue of 25,365,854 new ordinary shares of 1pence each in the company, at a price of 10.25p each.
At the AGM in June the company stressed that its flagship line product its agricultural fungicide product 3AEY has been successful. The product has got EU approval in Malta, Italy, Bulgaria, Greece and Spain as well as in Kenya.
6 Priory Court,
Priory Business Park,
Tel: +44 (0) 1285 359555:
Chairman: Tom Lupton
Managing Director: John Edmunds
CEO: Sean M. Smith
Short description: Eden utilises natural, plant-derived essential oils “Terpenes” to manufacture low-risk environmentally-friendly products such as fungicides.